Who Exports Dacarbazine from India — 193 Suppliers Behind a $1.4M Market
India's dacarbazine export market is supplied by 193 active exporters who collectively shipped $1.4M across 1,039 shipments. VENUS REMEDIES LIMITED leads with a 11.9% market share, followed by NAPROD LIFE SCIENCES PRIVATE LIMITED and UNITED BIOTECH PRIVATE LIMITED. The top 5 suppliers together control 41.9% of total export value, reflecting a moderately competitive market structure.
Top Dacarbazine Exporters from India — Ranked by Export Value
VENUS REMEDIES LIMITED is the leading dacarbazine exporter from India, holding a 11.9% share of the $1.4M market across 1,039 shipments from 193 exporters. The top 5 suppliers — VENUS REMEDIES LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, VHB MEDI SCIENCES LIMITED, NV REMEDIES PRIVATE LIMITED — collectively control 41.9% of total export value, indicating a competitive market. Individual shares are: VENUS REMEDIES LIMITED (11.9%), NAPROD LIFE SCIENCES PRIVATE LIMITED (9.4%), UNITED BIOTECH PRIVATE LIMITED (8.7%), VHB MEDI SCIENCES LIMITED (7.2%), NV REMEDIES PRIVATE LIMITED (4.8%).
Top Dacarbazine Exporters from India
Ranked by export value · 193 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | VENUS REMEDIES LIMITED DACAROL 200MG DACARBAZINE FOR INJECTIONDACAROL DACARBAZINE FOR INJECTION USP 20TOCLIZIN 200 MG (DACARBAZINE INJECTION 2 | $170.6K | 9 | 11.9% |
| 2 | NAPROD LIFE SCIENCES PRIVATE LIMITED DACARBAZINE FOR INJECTION USP 200MGARZI-200 DACARBAZINE FOR INJECTION USP 2ARZI-200 | $133.7K | 6 | 9.4% |
| 3 | UNITED BIOTECH PRIVATE LIMITED DACARBAZINE FOR INJECTION USP 200MGDACARBAZINE FOR INJECTION USP ONCODAC 200MGDACMED 200 | $123.6K | 10 | 8.7% |
| 4 | VHB MEDI SCIENCES LIMITED DACARBAZINE FOR INJECTION USP 200MGDACARBAZINE FOR INJECTION USP ONCODAC 200MGDACMED 200 | $102.7K | 3 | 7.2% |
| 5 | NV REMEDIES PRIVATE LIMITED | $68.3K | 2 | 4.8% |
| 6 | NEON LABORATORIES LIMITED DACARBAZINE FOR INJECTION USP 100MG/VIAL-ZICARB 100ZICARB 200 DACARBAZINE FOR INJECTION USPZICARB 100 DACARBAZINE FOR INJECTION USP | $63.9K | 3 | 4.5% |
| 7 | CELON LABORATORIES PRIVATE LIMITED DACARBAZINE FOR INJECTION USP 100MG/VIAL-ZICARB 100ZICARB 200 DACARBAZINE FOR INJECTION USPZICARB 100 DACARBAZINE FOR INJECTION USP | $52.8K | 8 | 3.7% |
| 8 | AXA PARENTERALS LIMITED TOCLIZIN 200 MG (DACARBAZINE INJECTION 2DACARBAZINE 200MG INJ.,DACARBAZINE FOR INJ. USP 100MG | $47.4K | 1 | 3.3% |
| 9 | VENUS REMEDIES LTD DACAROL 200MG DACARBAZINE FOR INJECTIONDACAROL DACARBAZINE FOR INJECTION USP 20TOCLIZIN 200 MG (DACARBAZINE INJECTION 2 | $46.3K | 1 | 3.2% |
| 10 | MILES INTERNATIONAL DACARBAZINE FOR INJECTION USP 200MGDACARBAZINE 200MG INJECTION MFG- NAPROD | $38.5K | 1 | 2.7% |
| 11 | RUS MED EXPORTS PVT. LTD. | $35.4K | 1 | 2.5% |
| 12 | DHEER HEALTH CARE PRIVATE LIMITED DCARBRIX 200 MG INJECTIONDETIZENE 200 MG INJ DACARBAZINECELDAZ 200MG INJ | $34.4K | 3 | 2.4% |
| 13 | AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED DACARBAZINE 200MG INJ. CELDAZ 200 INJ.B.CELDAZ-500INJ.(DACARBAZINE INJ.USP 500MGCELDAZ INJ.DACARBAZINE 200MG INJ.BN:CBDC | $34.4K | 1 | 2.4% |
| 14 | RMPL PHARMA LLP DCARBRIX 200 MG INJECTIONDACARBAZINE 200MG INJ. CELDAZ 200 INJ.B.CELDAZ-500INJ.(DACARBAZINE INJ.USP 500MG | $27.9K | 11 | 2.0% |
| 15 | UNITED BIOTECH PVT LTD DACARBAZINE FOR INJECTION USP 200MGDACARBAZINE FOR INJECTION USP ONCODAC 200MGDACMED 200 | $27.3K | 2 | 1.9% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Dacarbazine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Venus Remedies Limited | Not Listed | Yes | Yes | Not verified | EU GMP certification renewed by Infarmed, Portugal, in January 2025. |
| United Biotech Private Limited | Not Listed | Yes | No | Not verified | WHO GMP certified as per CDSCO list, February 2015. |
| VHB Medi Sciences Limited | Not Listed | Yes | No | Not verified | WHO GMP certified as per CDSCO list, February 2015. |
| Celon Laboratories Private Limited | Not Listed | Yes | No | Not verified | WHO GMP certified as per CDSCO list, February 2015. |
| Naprod Life Sciences Private Limited | Not Listed | Yes | No | Not verified | WHO GMP certified as per CDSCO list, February 2015. |
| Neon Laboratories Limited | Not Listed | Yes | No | Not verified | WHO GMP certified as per CDSCO list, February 2015. |
| Axa Parenterals Limited | Not Listed | Yes | No | Not verified | WHO GMP certified as per CDSCO list, February 2015. |
| Venus Remedies Ltd | Not Listed | Yes | Yes | Not verified | EU GMP certification renewed by Infarmed, Portugal, in January 2025. |
TransData Nexus reviewed the regulatory standing of 8 leading Dacarbazine exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Dacarbazine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city's well-established infrastructure and supportive regulatory environment have attracted numerous API manufacturers. This concentration facilitates efficient production and supply chain operations, making Hyderabad a critical node in the pharmaceutical landscape.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts a dense network of companies specializing in the development and manufacturing of finished dosage forms. The presence of facilities like the Zydus Infrastructure SEZ and Pharma Techno Park underscores the area's significance in formulation production.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a vital export gateway for Indian pharmaceuticals. Proximity to major ports and international airports enables efficient distribution of pharmaceutical products to global markets. This region's strategic location and robust logistics infrastructure make it a key player in India's pharmaceutical export activities.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives. These incentives have attracted numerous pharmaceutical companies, contributing to the region's rapid industrial growth and its role in the national pharmaceutical supply chain.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the technical and regulatory compliance capabilities of suppliers, especially those involved in API production, to ensure consistent quality.
- Leverage Export Hubs: Utilize the logistical advantages of export-oriented regions like Mumbai-Thane-Raigad for efficient international distribution.
- Monitor Regulatory Changes: Stay informed about regional tax incentives and regulatory policies that may impact supplier operations and cost structures.
By strategically sourcing from these diverse pharmaceutical clusters, companies can enhance supply chain resilience and ensure a steady supply of Dacarbazine to meet global demand.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Dacarbazine exporters from India
Venus Remedies Limited — Venus Remedies secures 230+ new marketing authorizations
In July 2025, Venus Remedies Limited announced the acquisition of over 230 new marketing authorizations, expanding their global footprint to more than 1,050 authorizations, with 430 active by Q4 FY25. - IMPACT: This expansion is expected to enhance Venus Remedies' Dacarbazine export capabilities, potentially increasing their market share.
Impact: This expansion is expected to enhance Venus Remedies' Dacarbazine export capabilities, potentially increasing their market share.
Common Questions — Dacarbazine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which dacarbazine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, VENUS REMEDIES LIMITED leads with 39 recorded shipments worth $170.6K. NAPROD LIFE SCIENCES PRIVATE LIMITED (16 shipments) and UNITED BIOTECH PRIVATE LIMITED (59 shipments) are also established high-volume exporters.
Q How many dacarbazine manufacturers are there in India?
India has 193 active dacarbazine exporters with a combined export market of $1.4M across 1,039 shipments to 110 countries. The top 5 suppliers hold 41.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for dacarbazine from India?
Average FOB unit price: $3.27 per unit, ranging from $0.01 to $99.26. Average shipment value: $1.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 193 verified Indian exporters of Dacarbazine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,039 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 110 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,039 Verified Shipments
193 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists